Tirilazad
From Self-sufficiency
File:Tirilazad.png | |
Systematic (IUPAC) name | |
---|---|
(16α)-21-[4-(2,6-dipyrrolidin-1-ylpyrimidin-4-yl)piperazin-1-yl]-16-methylpregna-1,4,9(11)-triene-3,20-dione | |
Identifiers | |
CAS Number | 110101-66-1 |
ATC code | N07XX01 (WHO) |
PubChem | CID 104903 |
Synonyms | (8S,10S,13S,14S,16R,17S)-17-[2-[4-(2,6-dipyrrolidin-1-ylpyrimidin-4-yl)piperazin-1-yl]acetyl]-10,13,16-trimethyl-6,7,8,12,14,15,16,17-octahydrocyclopenta[a]phenanthren-3-one |
Chemical data | |
Formula | C38H52N6O2 |
Molar mass | 624.859 g/mol[[Script error: No such module "String".]] |
Tirilazad is a drug proposed for use in the treatment of stroke, though results so far have been mixed.[1]
References
Cite error: Invalid <references>
tag;
parameter "group" is allowed only.
<references />
, or <references group="..." />
35px | This drug article relating to the nervous system is a stub. You can help ssf by expanding it. |
- ↑ "Tirilazad for acute ischaemic stroke". Retrieved 2007-07-28.
Categories:
- Pages with script errors
- Pages with broken file links
- Infobox drug tracked parameters
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- 2Fix
- Steroids
- Piperazines
- Pyrimidines
- Pyrrolidines
- Nervous system drug stubs